Assessing Hospice Needs in Patients with Different Medical Conditions

End-of-life care is an important consideration for patients with certain medical conditions. Hospice care is recommended for patients with a life expectancy of less than six months and who are no longer seeking curative treatment. Patients with end-stage dementia, for example, have limited life expectancy and may require hospice care. On the other hand, patients with relapsing-remitting multiple sclerosis may have palliative care needs but do not require hospice admission. Similarly, patients with moderate chronic obstructive pulmonary disease may require palliative care but do not need hospice admission. In contrast, patients with locally advanced prostate cancer may require hospice care and have treatment options such as watchful waiting, external radiotherapy with hormone therapy, surgery, hormone therapy on its own, cryotherapy as part of a clinical trial, or high-frequency ultrasound therapy (HIFU) as part of a clinical trial. Understanding the hospice needs of patients with different medical conditions is crucial for providing appropriate end-of-life care.

Myths about Hospice Care: Debunked

Hospice care is often misunderstood, leading to misconceptions about who can receive it and what it entails. Here are some common myths about hospice care debunked:

Myth #1: Hospice care is only for patients with terminal cancer.
Fact: Patients with any terminal diagnosis can seek hospice care, not just those with cancer. Commonly, patients with chronic lung disease, dementia, and neurodegenerative disorders benefit from hospice care.

Myth #2: Patients must be bed-bound to receive hospice care.
Fact: Mobility status does not affect admission to hospice. Patients in hospices often take part in activities and may be fully mobile.

Myth #3: Patients must have a ‘do not resuscitate’ (DNACPR) decision to receive hospice care.
Fact: Although most patients will have a DNACPR decision in a hospice, this is not a requirement.

Myth #4: Patients must have uncontrolled pain to receive hospice care.
Fact: While some patients may be admitted to a hospice for pain control, hospices are able to treat other symptoms, and pain control can be addressed in other settings, depending on the patient’s needs and wishes.

Hospice care and palliative care both focus on quality of life care for the patient and address adjustment to illness and end-of-life issues. Both forms of care address pain and symptom control issues for patients. However, hospice care is for patients who are no longer actively seeking curative treatment and have a terminal diagnosis with a life expectancy of 6 months or less. In contrast, for palliative care treatment, patients may still be undergoing aggressive treatment and do not have to be terminally ill. It is important to understand the facts about hospice care to make informed decisions about end-of-life care.

Assessing for Death: Signs and Symptoms

When diagnosing death, it is important to look for signs of life initially, including skin color, signs of respiratory effort, and response to verbal/painful stimuli. Painful stimuli can be assessed using various methods, such as fingernail bed pressure, supraorbital pressure, or trapezius squeeze. Pupils should be assessed using a pen torch, as they become fixed and dilated after death. A central pulse, such as the carotid pulse, should be palpated, and doctors should listen for heart sounds for at least two minutes and breath sounds for at least three minutes. Exact durations may vary, but a minimum of five minutes of auscultation should be conducted to confirm irreversible cardiorespiratory arrest.

However, assessing for a gag reflex is not a routine part of diagnosing death, and the absence of a gag reflex may not necessarily indicate death. Instead, the absence of a corneal reflex can be used to diagnose death.

It is important to note that one minute of auscultation for breath and heart sounds would be insufficient to diagnose death. Additionally, assessing for a peripheral pulse, such as the radial pulse, would not be accurate, as it can be lost in peripherally shut down or hypotensive patients. Confirmation of death requires the absence of a central pulse, such as the carotid pulse, and the absence of breath and heart sounds for an adequate amount of time, along with fixed and dilated pupils.

The Importance of Pain Control in Palliative Care

Pain is a crucial aspect of palliative care management. It is a multifaceted symptom that can impact a patient’s mobility, appetite, sleep, and overall quality of life. Addressing pain may involve improving mobility, which can help patients get out of bed and move around more easily. Pain control is also associated with better appetite and sleep, as well as reducing anxiety and improving general quality of life. Therefore, pain control is an essential component of palliative care that can significantly enhance a patient’s well-being.

Different Approaches to Managing a Palliative Care Patient’s Symptoms

When managing a patient in palliative care, it is important to consider the best approach to managing their symptoms. Here are some different approaches and their potential outcomes:

1. Prescribe alfentanil via syringe driver for pain relief: This is a good option for patients with renal failure or opiate toxicity problems.

2. Advise the patient to take only paracetamol and NSAIDs for pain: This may not be effective for patients experiencing severe pain, and they may not be able to swallow safely.

3. Admit the patient to hospital: This may not be in line with the patient’s wishes to remain at home during the final stages of their life.

4. Continue the current regime and advise the family: This may not address the patient’s symptoms and could lead to unnecessary suffering.

5. Reduce the dose of diamorphine and add haloperidol to the syringe driver: This may not be effective if the patient’s symptoms are due to a reversible cause.

Overall, it is important to consider the patient’s individual needs and wishes when managing their symptoms in palliative care.

Causes of Acid-Base Imbalances: Explanation and Examples

Vomiting: When a patient’s arterial blood gas shows an uncompensated metabolic alkalosis, it suggests an acute cause such as vomiting. Vomiting causes a loss of stomach acid, resulting in fewer H+ ions to bind to HCO3-, leading to more free HCO3- and resulting in a metabolic alkalosis.

Aspirin Overdose: An aspirin overdose typically causes an initial respiratory alkalosis followed by a metabolic acidosis with a raised anion gap. The respiratory alkalosis is the result of direct stimulation of the medulla, while the metabolic acidosis is caused by an accumulation of lactic acid due to an uncoupling of oxidative phosphorylation.

Anxiety: Hyperventilation associated with anxiety would cause a respiratory alkalosis. This is due to ‘blowing off’ carbon dioxide through hyperventilation, resulting in a decreased PaCO2 in the blood and an increased ratio of HCO3− to PaCO2, raising the pH and resulting in alkalosis.

Pulmonary Embolism: A pulmonary embolism would cause a respiratory alkalosis, usually accompanied by hypoxia or type I respiratory failure.

Respiratory Depression: Respiratory depression would cause a respiratory acidosis. Hypoventilation means that less carbon dioxide is blown off, resulting in an increase in PaCO2 in the blood, which decreases the pH.

Medications for Managing Bowel Obstruction in End-of-Life Care

Bowel obstruction during end-of-life care can be managed without surgery or nasogastric tube placement. Loperamide hydrochloride, an antidiarrhoeal medication, can provide relief by reducing bowel motility when used with an opiate analgesic. Ondansetron, an antiemetic, can treat nausea but may cause constipation by slowing gastric stasis. Dexamethasone can alleviate bowel discomfort by reducing inflammation and oedema caused by a tumour obstructing the bowel. Lorazepam can help alleviate distress or anxiety caused by symptoms, but it does not improve them. Paracetamol is a weak analgesic and is unlikely to relieve discomfort in this case.

Choosing the Right Opioid for Inadequate Pain Control

Explanation:

When a patient has inadequate pain control on a weak opiate and non-opiate combination, it’s important to consider switching to a strong opiate. However, choosing the right opioid requires careful consideration of the patient’s needs and potential risks.

One option is to stop codeine and start morphine sulphate modified release at a low dose, with the intention of titrating the dose slowly to reduce the risk of overdose. Short-acting morphine can be used for breakthrough pain, and the dose of the modified release morphine can be adjusted as needed.

On the other hand, switching to co-codamol or dihydrocodeine may not provide sufficient pain relief for this patient. Co-codamol at the same dose as the current codeine regimen would not improve pain control, while dihydrocodeine may require higher doses than morphine.

Finally, tramadol is a weak opioid and may not be effective for this patient’s level of pain. Instead, starting with a low dose of morphine and titrating slowly may be the best option for achieving adequate pain control while minimizing the risk of adverse effects.

Options for Managing Inadequate Pain Relief in a Patient on Opiates

When a patient on opiates experiences inadequate pain relief, there are several options for managing their medication. One option is to increase the dose of modified release morphine sulphate tablets (MST) while advising the patient to reduce the frequency of breakthrough medication, such as oramorph. However, caution must be taken to avoid overdose, and the patient should be aware of the risks of continuing their current regime.

Another option is to switch to a different opiate, such as oxycodone, but this may not be necessary if the patient is tolerating the current medication well. In this case, the dose of MST can be titrated cautiously and reviewed regularly.

A fentanyl patch may also be an option, but only if the patient is unable to take tablets due to eating or drinking difficulties.

If the patient requires multiple doses of breakthrough medication, the BNF recommends reviewing the dose of longer-acting analgesia.

Ultimately, the best course of action will depend on the individual patient’s needs and condition, and a full review of their medication and pain management plan should be performed if necessary.

Managing Pain in a Palliative Care Patient: Dosage Adjustments and Adjuncts

When managing pain in a palliative care patient, it is important to consider the appropriate dosage adjustments and adjuncts to provide effective pain relief. In the given scenario, the patient was taking 60 mg of morphine (as MST) and required another 30 mg of Oramorph® per day for breakthrough pain, resulting in a total daily dose of 90 mg. To address uncontrolled pain, the MST dose was increased to 45 mg bd and the Oramorph® dose was adjusted to 15 mg prn, with the breakthrough dose being one-sixth of the total daily dose.

While dexamethasone may be considered as an adjunct for liver capsule pain, amitriptyline is not indicated for neuropathic pain in this case. Increasing the dose of ibuprofen is also unlikely to provide significant pain relief. Instead, it is advisable to stick to oral morphine and adjust the dosage accordingly.

In some cases, a continuous subcutaneous infusion of morphine sulfate may be necessary, but it is preferable to use the oral route when possible to reduce the risk of infection and improve patient comfort. Overall, careful consideration of dosage adjustments and adjuncts can help provide effective pain relief for palliative care patients.